[1]
« IL-23 Inhibitors in Psoriasis: A Canadian Dermatology Roundtable », Can Dermatol Today, vol. 7, nᵒ s03, p. 2–9, sept. 2026, doi: 10.58931/cdt.2026.7s03166.